The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Galanthamine from snowdrop—the development of a modern drug against Alzheimer’s disease from local Caucasian knowledge
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
(1958) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030470133 · Cited by 2,489
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Evans, D. A. (1989) · JAMA · doi:10.1001/jama.262.18.2551 · Cited by 1,626
An english translation of alzheimer’s 1907 paper, “über eine eigenartige erkankung der hirnrinde”
Stelzmann, R. A., Norman Schnitzlein, H., & Reed Murtagh, F. (1995) · Clinical Anatomy · doi:10.1002/ca.980080612 · Cited by 1,455
Knapp, M. J. (1994) · JAMA · doi:10.1001/jama.271.13.985 · Cited by 1,004
A 5-month, randomized, placebo-controlled trial of galantamine in AD
Tariot, P. N., Solomon, P. R., Morris, J. C., Kershaw, P., Lilienfeld, S., Ding, C., & the Galantamine USA- Study Group (2000) · Neurology · doi:10.1212/wnl.54.12.2269 · Cited by 921
Raskind (2000) · doi:10.1212/wnl.54.12.2261 · Cited by 870
Erkinjuntti, T., Kurz, A., Gauthier, S., Bullock, R., Lilienfeld, S., & Damaraju, C. V. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08267-3 · Cited by 752
Nicotinic acetylcholine involvement in cognitive function in animals
Levin, E. D., & Simon, B. B. (1998) · Psychopharmacology · doi:10.1007/s002130050667 · Cited by 678
Wilcock, G. K., Lilienfeld, S., & Gaens, E. (2000) · BMJ · doi:10.1136/bmj.321.7274.1445 · Cited by 626
NEOCORTICAL CHOLINERGIC NEURONS IN ELDERLY PEOPLE
White, P., Goodhardt, M. J., Keet, J. P., Hiley, C. R., Carrasco, L. H., Williams, I. E. I., & Bowen, D. M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92114-6 · Cited by 489
Albuquerque, E. X., Alkondon, M., Pereira, E. F. R., Castro, N. G., Schrattenholz, A., Barbosa, C. T. F., Bonfante-Cabarcas, R., Aracava, Y., Eisenberg, H. M., & Maelicke, A. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36503-6 · Cited by 445
A Controlled Trial of Tacrine in Alzheimer's Disease
Farlow, M. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490180055026 · Cited by 398
A CLICKING HIP IN A NEWBORN BABY SHOULD NEVER BE IGNORED
Cunningham, K. T., Beningfield, S., Moulton, A., & Maddock, C. R. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92180-9 · Cited by 387
Estimated Prevalence of Alzheimer's Disease in the United States
Evans, D. A. (1990) · The Milbank Quarterly · doi:10.2307/3350099 · Cited by 357
Crook, R., Verkkoniemi, A., Perez-Tur, J., Mehta, N., Baker, M., Houlden, H., Farrer, M., Hutton, M., Lincoln, S., Hardy, J., et al. (1998) · Nature Medicine · doi:10.1038/nm0498-452 · Cited by 349
Ethnopharmacology in drug discovery: an analysis of its role and potential contribution
Heinrich, M., & Gibbons, S. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775712 · Cited by 300
Self-citationEffects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial
Rockwood, K. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.5.589 · Cited by 279
Bores, G. M., Huger, F. P., Petko, W., Mutlib, A. E., Camacho, F., Rush, D. K., Selk, D. E., Wolf, V, Kosley, R. W., Davis, L., et al. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12928-5 · Cited by 248
Lehrbuch der biologischen Heilmittel
(1938) · Journal of the American Medical Association · doi:10.1001/jama.1938.02790170074033 · Cited by 241
Schrattenholz, A., Pereira, E. F., Roth, U., Weber, K. H., Albuquerque, E. X., & Maelicke, A. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08675-4 · Cited by 226
Galantamine: a randomized, double‐blind, dose comparison in patients with Alzheimer's disease
Wilkinson, D., Murray, J., & the Galantamine Research Group (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.409 · Cited by 212
Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo
Thomsen, T., & Kewitz, H. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90429-u · Cited by 207
Ethnopharmacologic Search for Psychoactive Drugs.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-4-585_4 · Cited by 193
Galantamine: Effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning
Woodruff-Pak, D. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031584398 · Cited by 188
Cholinergic Basis for Alzheimer Therapy
(1991) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4899-6738-1 · Cited by 181
The pharmacology of galanthamine and its analogues
Harvey, A. L. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)02002-0 · Cited by 169
Kwok, J. B. J., Taddei, K., Hallupp, M., Fisher, C., Brooks, W. S., Broe, G. A., Hardy, J., Fulham, M. J., Nicholson, G. A., Stell, R., et al. (1997) · NeuroReport · doi:10.1097/00001756-199704140-00043 · Cited by 160
Saper, C. B., German, D. C., & White, C. L. (1985) · Neurology · doi:10.1212/wnl.35.8.1089 · Cited by 159
CHOLINERGIC APPROACHES TO THE TREATMENT OF ALZHEIMER'S DISEASE
Hollander, E., Mohs, R. C., & Davis, K. L. (1986) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072106 · Cited by 158
Clinical Diagnosis and Management of Alzheimer's Disease
(2006) · CRC Press eBooks · doi:10.3109/9780203931714 · Cited by 154
Pereira, E. F. R., Reinhardt-Maelicke, S., Schrattenholz, A. S., Maelicke, A., & Albuquerque, E. X. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38284-4 · Cited by 125
Storch, A., Schrattenholz, A. S., Cooper, J. C., Ghani, E. M. A., Gutbrod, O., Weber, K. H., Reinhardt, S., Lobron, C., Hermsen, B., Šoškić, V., et al. (1995) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(95)00080-1 · Cited by 116
The Cognitive Psychopharmacology of Alzheimer's Disease: Focus on Cholinergic Systems
Lawrence, A. D., & Sahakian, B. J. (1998) · Neurochemical Research · doi:10.1023/a:1022419712453 · Cited by 111
d-cycloserine attenuates scopolamine-induced learning and memory deficits in rats
Fishkin, R. J., İnce, E., Carlezon, W. A., & Dunn, R. W. (1993) · Behavioral and Neural Biology · doi:10.1016/0163-1047(93)90886-m · Cited by 108
Chopin, P., & Briley, M. (1992) · Psychopharmacology · doi:10.1007/bf02253584 · Cited by 103
Pharmacokinetics of galanthamine in humans and corresponding cholinesterase inhibition
Bickel, U., Thomsen, T., Weber, W., Fischer, J. P., Bachus, R., Nitz, M., & Kewitz, H. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.159 · Cited by 94
Thomsen, T., Kaden, B., Fischer, J. P., Bickel, U., Barz, H., Gusztony, G., Cervós‐Navarro, J., & Kewitz, H. (1991) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1991.29.8.487 · Cited by 92
Thomsen, T., Zendeh, B., Fischer, J. P., & Kewitz, H. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90022-w · Cited by 87
A long-acting cholinesterase inhibitor reverses spatial memory deficits in mice
Sweeney, J. E., Höhmann, C. F., Moran, T. H., & COYLE, J. T. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90325-5 · Cited by 85
Sweeney, J. E., Bachman, E. S., & Coyle, J. T. (1990) · Psychopharmacology · doi:10.1007/bf02245921 · Cited by 79
Sweeney, J. E., Puttfarcken, P. S., & Coyle, J. T. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90364-x · Cited by 65
The cholinergic deficit in Alzheimer's disease.
Whitehouse, P. J. (1998) · PubMed · Cited by 63
Fulton, B., & Benfield, P. (1996) · Drugs & Aging · doi:10.2165/00002512-199609010-00006 · Cited by 58
Homerʼs Moly Identified as Galanthus nivalis L.
Plaitakis, A., & Duvoisin, R. C. (1983) · Clinical Neuropharmacology · doi:10.1097/00002826-198303000-00001 · Cited by 55
Galanthamine in Alzheimer??s Disease
Rainer, M. K. (1997) · CNS Drugs · doi:10.2165/00023210-199707020-00001 · Cited by 50
The O-demethylation of the antidementia drug galanthamine is catalysed by cytochrome P450 2D6
Bachus, R., Bickel, U., Thomsen, T., Roots, I., & Kewitz, H. (1999) · Pharmacogenetics · doi:10.1097/00008571-199912000-00001 · Cited by 50
Pharmacokinetics of Galanthamine Hydrobromide after Single Subcutaneous and Oral Dosage in Humans
Mihailova, D., Yamboliev, I., Zhivkova, Z. D., Tencheva, J., & Jovovich, V. (2008) · Pharmacology · doi:10.1159/000138571 · Cited by 49
Age‐related loss of calbindin from human basal forebrain cholinergic neurons
Wu, C.-K., Mesulam, M., & Geula, C. (1997) · NeuroReport · doi:10.1097/00001756-199707070-00024 · Cited by 45
Farlow, M. R. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80164-8 · Cited by 42
The Second Generation of Cholinesterase Inhibitors: Pharmacological Aspects
Giacobini, E. (1991) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4899-6738-1_29 · Cited by 38
Partial reversal of anticholinergic amnesia by choline chloride
Mohs, R. C., Davis, K. L., & Levy, M. I. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90674-3 · Cited by 28
Zhao, Q., Iyer, G. R., Verhaeghe, T., & Truyen, L. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/0091270002424009 · Cited by 28
Geschichte und Volkskunde der deutschen Heilpflanzen
Marzell, H. (1938) · Medical Entomology and Zoology · Cited by 27
Pharmacokinetics and metabolism of galanthamine
Kewitz, H. (1997) · Drugs of today · doi:10.1358/dot.1997.33.4.425052 · Cited by 27
Tacrine Development Experience
Schneider, L. S. (1994) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199424000-00003 · Cited by 19
Cited by
A Historical Overview of Natural Products in Drug Discovery
Dias, D. A., Urban, S., & Roessner, U. (2012) · Metabolites · doi:10.3390/metabo2020303 · Cited by 1,958
Drug discovery from medicinal plants
Balunas, M. J., & Kinghorn, A. D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.09.012 · Cited by 1,810
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
Choudhari, A. S., Mandave, P. C., Deshpande, M., Ranjekar, P., & Prakash, O. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01614 · Cited by 1,086
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Drug discovery from natural sources
Chin, Y.-W., Balunas, M. J., Chai, H. B., & Kinghorn, A. D. (2006) · The AAPS Journal · doi:10.1007/bf02854894 · Cited by 662
Metadata
- Authors
- Heinrich, M., & Lee Teoh, H.
- Venue
- Journal of Ethnopharmacology
- Publisher
- Elsevier BV
- Published
- 2004-06
- Volume
- 92
- Issue
- 2-3
- Pages
- 147-162
- ISSN
- 0378-8741 (ISSN-L)
- OpenAlex
- W1964095432
- Cited by
- 584
- References
- 59
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.